Cytokinetics Inc (CYTK) — Cash Flow Reinvestment Rate
Cytokinetics Inc (CYTK) has a Cash Flow Reinvestment Rate of 3.33x as of December 2020, reinvesting $173.62 Million (capex $6.55 Million plus investments $-167.06 Million) from operating cash flow of $52.15 Million. Explore capital reinvestment ratio of Cytokinetics Inc to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cytokinetics Inc Cash Flow Reinvestment Rate (2009–2020)
Historical reinvestment intensity for Cytokinetics Inc across 4 annual periods. Also explore Cytokinetics Inc (CYTK) total assets for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Cytokinetics Inc (2009–2020)
Year-by-year capital reinvestment analysis for Cytokinetics Inc. For live market cap and broader valuation context, see how much is Cytokinetics Inc worth.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2020 | 21.97x | $196.51 Million | $8.94 Million | $11.05 Million | ▲ +1459.5% |
| 2016 | 1.41x | $52.11 Million | $36.98 Million | $1.60 Million | ▼ -60.0% |
| 2015 | 3.52x | $17.19 Million | $4.88 Million | $562.00K | ▲ +5285.6% |
| 2009 | 0.07x | $550.00K | $8.42 Million | $550.00K | — |